Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about COX4I1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
COX4I1 is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, inhibits. Associated with Aging, Als, Cardiovascular. Connected to 130 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | COX4I1 |
| Full Name | Cytochrome C Oxidase Subunit 4I1 |
| Chromosome | 16q24.1 |
| Protein Type | Enzyme |
| Target Class | Enzyme |
| Function | encodes a critical subunit of the mitochondrial electron transport chain Complex IV (cytochrome c oxidase). |
| Mechanism of Action | Drugs targeting COX4I1 pathway would enhance electron transport chain efficiency or stabilize complex IV assembly, improving ATP production and reducing oxidative stress in mitochondria. These agents work by either promoting mitochondrial bioenergetics, acting as electron donors/acceptors, or preventing complex IV degradation in diseases with impaired oxidative phosphorylation. |
| Primary Expression | Brain, Heart, Skeletal Muscle |
| Druggability | Low (0.42) |
| Clinical Stage | Phase II |
| Pathways | Mitochondrial dynamics / bioenergetics |
| UniProt ID | P12074 |
| NCBI Gene ID | 1024 |
| Ensembl ID | ENSG00000131043 |
| GeneCards | COX4I1 |
| Human Protein Atlas | COX4I1 |
| Associated Diseases | Aging, Cardiovascular, Ischemia, neurodegeneration |
| Known Drugs/Compounds | Elamipretide (MTP131), Idebenone, Coenzyme Q10 (Ubiquinone), SS-31 (Szeto-Schiller peptide 31) |
| Interactions | AGING, AIF1, AMPK, ARC, ATF3, AUTOPHAGY |
| SciDEX Target | View Target Profile (7 clinical trials) |
| SciDEX Hypotheses | Near-infrared light therapy stimulates COX4-depend |
| KG Connections | 325 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
COX4I1["COX4I1"]
COX4I1 -->|"inhibits"| Aging["Aging"]
COX4I1 -->|"inhibits"| Ms["Ms"]
COX4I1 -->|"inhibits"| Cardiovascular["Cardiovascular"]
COX4I1 -->|"inhibits"| Mitophagy["Mitophagy"]
COX4I1 -->|"inhibits"| Proteasome["Proteasome"]
COX4I1 -->|"activates"| GRIA2["GRIA2"]
h_fd1562a3["h-fd1562a3"] -->|"target for"| COX4I1
MYO7A["MYO7A"] -->|"activates"| COX4I1
MAP1LC3B["MAP1LC3B"] -->|"activates"| COX4I1
OPTN["OPTN"] -->|"activates"| COX4I1
PARKIN["PARKIN"] -->|"activates"| COX4I1
PINK1["PINK1"] -->|"activates"| COX4I1
XBP1["XBP1"] -->|"activates"| COX4I1
ATF3["ATF3"] -->|"activates"| COX4I1
TOMM20["TOMM20"] -->|"activates"| COX4I1| Target | Relation | Type | Str |
|---|---|---|---|
| oxidative phosphorylation | involved_in | pathway | 0.90 |
| OXPHOS | involved_in | pathway | 0.90 |
| ATP synthesis | suppresses | process | 0.80 |
| cytochrome_c_oxidase | encodes | protein | 0.80 |
| ubiquitin-proteasome | participates_in | pathway | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| ALS | protects_against | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Neurodegeneration | protects_against | disease | 0.65 |
| Inflammation | protects_against | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Neuroinflammation | protects_against | disease | 0.65 |
| Cardiovascular | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Ischemia | associated_with | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Cardiovascular | degrades | disease | 0.65 |
| Aging | degrades | disease | 0.65 |
| neurodegeneration | associated_with | disease | 0.63 |
| neural stem cells | regulates | cell_type | 0.60 |
| PRKN | associated_with | gene | 0.60 |
| GRIA2 | activates | gene | 0.60 |
| PRKN | activates | gene | 0.60 |
| HSPD1 | activates | gene | 0.60 |
| GAPDH | associated_with | gene | 0.60 |
| MAP1LC3A | associated_with | gene | 0.60 |
| PARKIN | associated_with | gene | 0.60 |
| SLC2A1 | inhibits | gene | 0.60 |
| NRXN3 | inhibits | gene | 0.60 |
| PRKAA1 | inhibits | gene | 0.60 |
| BDNF | inhibits | gene | 0.60 |
| SOD1 | inhibits | gene | 0.60 |
| NLGN2 | inhibits | gene | 0.60 |
| CYCS | inhibits | gene | 0.60 |
| PDHA1 | inhibits | gene | 0.60 |
| SOD2 | protects_against | gene | 0.60 |
| CAT | inhibits | gene | 0.60 |
| SLC2A2 | inhibits | gene | 0.60 |
| Autophagy | activates | pathway | 0.60 |
| Mitophagy | associated_with | pathway | 0.60 |
| Proteasome | associated_with | pathway | 0.60 |
| LC3B | activates | gene | 0.60 |
| Oxidative Stress | inhibits | pathway | 0.60 |
| AGING | inhibits | gene | 0.60 |
| Neuron | inhibits | cell_type | 0.60 |
| PKM | inhibits | gene | 0.60 |
| Bdnf | inhibits | protein | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-fd1562a3 | targets | hypothesis | 0.90 |
| Melamine | downregulates | compound | 0.90 |
| PS-COOH | downregulates | compound | 0.90 |
| PM10 | downregulates | compound | 0.85 |
| melamine | downregulates | compound | 0.85 |
| Ps-Cooh | downregulates | compound | 0.80 |
| MITOPHAGY | inhibits | gene | 0.60 |
| PKM | inhibits | gene | 0.60 |
| ATG7 | interacts_with | entity | 0.60 |
| BCL2L13 | interacts_with | entity | 0.60 |
| BNIP3L | interacts_with | entity | 0.60 |
| GENES | inhibits | gene | 0.60 |
| CREB | protects_against | gene | 0.60 |
| GLUT4 | protects_against | gene | 0.60 |
| OXIDATIVE STRESS | inhibits | gene | 0.60 |
| PER | protects_against | gene | 0.60 |
| NEURODEGENERATION | protects_against | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | protects_against | gene | 0.60 |
| NEUROINFLAMMATION | protects_against | gene | 0.60 |
| ATG7 | protects_against | gene | 0.60 |
| BCL2 | protects_against | gene | 0.60 |
| BNIP3L | protects_against | gene | 0.60 |
| BCL2L13 | protects_against | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| MITOPHAGY | degrades | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| UBIQUITIN | associated_with | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| HSP60 | activates | gene | 0.60 |
| OPTINEURIN | activates | gene | 0.60 |
| NRXN3 | inhibits | gene | 0.60 |
| LC3B | activates | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| CAT | associated_with | gene | 0.60 |
| NIX | associated_with | gene | 0.60 |
| GSK3B | inhibits | gene | 0.60 |
| INFLAMMATION | protects_against | gene | 0.60 |
| PDHA1 | inhibits | gene | 0.60 |
| BDNF | inhibits | gene | 0.60 |
| PRKAA1 | inhibits | gene | 0.60 |
| SOD2 | protects_against | gene | 0.60 |
| SOD1 | inhibits | gene | 0.60 |
| NLGN2 | inhibits | gene | 0.60 |
| PSD95 | protects_against | gene | 0.60 |
| CYCS | inhibits | gene | 0.60 |
| CAT | inhibits | gene | 0.60 |
| SLC2A2 | inhibits | gene | 0.60 |
| SLC2A1 | inhibits | gene | 0.60 |
| COX15 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Near-infrared light therapy stimulates COX4-dependent mitoch | 0.742 | neurodegeneration | Mitochondrial transfer between astrocyte |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.822
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| s:** - Test MCU overexpression specifically in layer II neurons in hea | falsification | Neurodegeneration | 0.400 | 0.50 | mouse | proposed | $200,000 |
| Proposed experiment from debate on Mitochondrial transfer between astr | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Ferroptosis Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| GLP-1 Agonist Neuroprotection Mechanism in PD | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Cytochrome Therapeutics | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Peroxisomal Dysfunction Validation in Parkinson's Disease | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Prodromal Parkinson's Disease Biomarker Development — Early Detection | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Synaptic Mitochondrial Resilience Enhancement for Parkinson's Disease | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
| Wilson Disease Neurodegeneration: Mechanism and Therapeutic Response | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $7,500,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Increased mitophagy protects cochlear hair cells from aminoglycoside-induced dam [PMID:35471096] | Zhang Y, Fang Q, Wang H, Qi J, Sun S, Li | Autophagy | 2023 | 1 |
| BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains. [PMID:32722981] | Wu X, Zheng Y, Liu M, Li Y, Ma S, Tang W | Autophagy | 2021 | 1 |
| SIRT5 regulation of ammonia-induced autophagy and mitophagy. [PMID:25700560] | Polletta L, Vernucci E, Carnevale I, Arc | Autophagy | 2015 | 1 |
| PRKAB2 as a tumor suppressor in renal cell carcinoma: inhibiting mitophagy via t [PMID:41612594] | Chen K, Zhang Y, Ruan H, Wei Z, Wang K, | Autophagy | 2026 | 0 |
| ROS-responsive nanogels for brain targeted delivery of icariin in the treatment [PMID:41197818] | ["Li X", "Huang J", "Zhou Y", "Chen X", | International journal of pharm | 2026 | 0 |
| Single-Cell RNA Sequencing and Network Pharmacology Reveal the Potential Role of [PMID:41610872] | ["Niu J", "Wang L", "Qi J", "Lu G"] | The journal of gene medicine | 2026 | 0 |
| Integrated Profiling of DEHP-Induced Hippocampal Neurotoxicity in Adult Female R [PMID:41600627] | Bai J, Li J, Tang L, Sun W, Gao F, Zhang | Toxics | 2026 | 0 |
| Functional and Molecular Characterization of Melamine-Induced Disruption of Huma [PMID:41596180] | ["Luongo F", "Annunzi E", "Ponchia R", " | Antioxidants (Basel, Switzerla | 2026 | 0 |
| Exploring the lactate-metabolism related characteristics during the development [PMID:41815173] | Wang C, Zhang R, Li S, Kang Z, Xia S, Li | Translational cancer research | 2026 | 0 |
| Developmental toxicity of carboxylated microplastics in zebrafish mediated by mi [PMID:41265820] | ["Li Y", "Ni Y", "Dong C", "Zhang J", "G | Environmental pollution (Barki | 2026 | 0 |
| Complex IV deficiency due to COX4I1 deep intronic and de novo variants results i [PMID:41203052] | Ugarteburu O, Farré-Tarrats L, Muñoz-Puj | Mitochondrion | 2026 | 0 |
| Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078] | ["Ranjitha V", "Kumar A", "Kaalappa P"] | Pharmaceutical research | 2025 | 0 |
| 810-nm Photobiomodulation Evokes Glutamate Release in Normal and Rotenone-Dysfun [PMID:39851493] | ["Ravera S", "Farsetti E", "Maura G", "M | Cells | 2025 | 0 |
| Mongolian medicine Wulanwendusu-11 alleviates myocardial ischemia-reperfusion in [PMID:41586357] | ["Wuyunsiqin", "Bai T", "Yang D", "Hashe | Frontiers in microbiology | 2025 | 0 |
| Near-Infrared Photoimmunotherapy in Brain Tumors-An Unexplored Frontier. [PMID:40430568] | ["Yamaguchi H", "Okada M", "Otani T", "O | Pharmaceuticals (Basel, Switze | 2025 | 0 |
| Evaluation of local and systemic photobiomodulation in only single-implant inser [PMID:40531278] | ["Pucca D", "Pinheiro S"] | Oral and maxillofacial surgery | 2025 | 0 |
| Comparison of the efficacy of 12 interventions in the treatment of diabetic foot [PMID:40821981] | ["Hu X", "Meng H", "Liang J", "An H", "Z | PeerJ | 2025 | 0 |
| Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] | ["Sanadgol N", "Abedi M", "Hashemzaei M" | Journal of nanobiotechnology | 2025 | 0 |
| Dose-dependent effects of transcranial photobiomodulation on brain temperature i [PMID:39370461] | ["Weerasekera A", "Coelho D", "Ratai E", | Lasers in medical science | 2024 | 0 |
| Mystery of gamma wave stimulation in brain disorders. [PMID:39695746] | ["Deng Q", "Wu C", "Parker E", "Zhu J", | Molecular neurodegeneration | 2024 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning COX4I1 in their description or question text
No additional research found